Takeda Pharmaceutical
TAK
#371
Rank
NZ$119.57 B
Marketcap
NZ$37.43
Share price
0.33%
Change (1 day)
53.62%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2026 (TTM): NZ$0.96 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are NZ$29.55 Billion. In 2025 the company made an earning of NZ$5.90 Billion, an increase over its 2024 earnings that were of NZ$3.96 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.96 B-83.62%
2025 NZ$5.90 B49.03%
2024 NZ$3.96 B-2.41%
2023 NZ$4.05 B-28.14%
2022 NZ$5.64 B-40.9%
2021 NZ$9.55 B78.24%
2020 NZ$5.36 B246.1%
2019 NZ$1.54 B-48.79%
2018 NZ$3.02 B-23.64%
2017 NZ$3.96 B21.7%
2016 NZ$3.25 B-253.01%
2015 -NZ$2.13 Billion-159.65%
2014 NZ$3.56 B13%
2013 NZ$3.15 B2.46%
2012 NZ$3.07 B-57.05%
2011 NZ$7.16 B-10.49%
2010 NZ$8.00 B-3.99%
2009 NZ$8.34 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$33.22 B 3,523.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$22.43 B 2,347.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$12.25 B 1,236.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$18.25 B 1,891.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$12.70 B 1,285.97%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$13.64 B 1,388.50%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$12.69 B 1,284.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-NZ$1.41 Billion-253.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
NZ$0.75 B-17.25%๐Ÿ‡ฎ๐Ÿ‡ณ India